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Objective: To compare measurements of retinal thick-
ness in eyes with mild nonproliferative retinopathy in pa-
tients with type 2 diabetes mellitus using 2 different tech-
niques: the retinal thickness analyzer (RTA) and optical
coherence tomography (OCT).
Methods: Twenty-eight eyes from 28 patients with type
2 diabetes mellitus and mild nonproliferative retinopa-
thy were classified according to the Wisconsin grading
system by 7-field stereoscopic fundus photography. Ten
eyes were classified as level 10 (absence of visible le-
sions) and 18 as level 20 or 35 (minimal retinopathy).
All eyes were examined by the RTA and OCT. Healthy
populations were used to establish reference maps for the
RTA (n=14; mean age, 48 years; age range, 42-55 years)
and OCT (n=10; mean age, 56 years; age range, 43-
68 years). Reference maps were computed using the
means+2 SDs of the values obtained for each location.
Increases in thickness were computed as a percentage of
increase over these reference maps.
Results: The RTA detected increases in thickness in 1
or more locations in 24 of the 28 diabetic eyes exam-
ined, whereas OCT detected increases in only 3 eyes. The
percentages of increase detected by the RTA ranged from
0.3% to 73.5%, whereas OCT detected percentages of in-
crease of 0.3% to 4.8%.
Conclusion: Optical coherence tomography is less
sensitive than the RTA in detecting localized increases
in retinal thickness in the initial stages of diabetic retinal
disease.
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D IABETIC RETINOPATHY(DR)remains a leading cause ofblindness in developedcountries. Macular edemais a frequent alteration in
type 2 diabetes mellitus and the most fre-
quent cause of visual loss.1 It has been con-
sidered to be mainly due to abnormal fluid
accumulation resulting from a breakdown
of the blood-retinal barrier.2
A definition of clinically significant
macular edema (CSME) has been pro-
posed by the Early Treatment Diabetic
Retinopathy Study (ETDRS).3 Current di-
agnostic methods for its detection and
evaluation are slitlamp biomicroscopy
(SLB) and stereoscopic fundus photogra-
phy (SFP), providing a subjective evalu-
ation of retinal thickness.
Detection of retinal thickening by
means of SLB or SFP, however, seems to be
associated with relatively low sensitivity. A
study by Shahidi et al4 using the retinal
thickness analyzer (RTA) shows that SLB
and SFP may detect increases in thickness
only when they show values of more than
60% greater than the reference population
and may, therefore, be unable to identify
mild or localized macular thickening.
Improved detection of macular edema
is expected to offer new perspectives for the
follow-up and treatment of DR. The ETDRS,
which is based on SLB and SFP findings,
has demonstrated that photocoagulation for
CSME only reduces the risk of moderate vi-
sual loss by approximately 50%.2
Optical imaging instruments, such as
the RTA (Talia Technology Ltd, Mevaseret,
Israel) and optical coherence tomography
(OCT) (Zeiss Humphrey Systems, Dublin,
Calif), have been proposed as powerful tools
for the objective assessment of macular
edema. It seems desirable to test these meth-
ods when minimal changes in retinal thick-
ness may be present, when other methods
cannot identify changes, and when visual
acuity is not affected. Both techniques,
which are capable of measuring retinal
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thickness and rapidly generating thickness maps at the pos-
terior pole,5,6 are noninvasive and noncontact procedures.
We used the RTA and OCT to measure retinal thick-
ness in the eyes of healthy volunteers and diabetic pa-




Twenty-eight patients (10 men and 18 women), aged 50 to 69
years (mean±SD age, 59.2±5.4 years), with an established di-
agnosis of type 2 diabetes mellitus were recruited to partici-
pate in this study. Duration of diabetes mellitus ranged from 1
to 20 years (mean±SD, 7.9±4.8 years), and glycosylated he-
moglobin values ranged from 5.5% to 11.7% (mean±SD,
7.3%±1.5%). Blood pressure levels were 155/85 mm Hg or less.
All patients underwent a complete ophthalmologic exami-
nation, including the following assessments: corneal refractive
power, refractiveerrorandbest-correctedvisual acuity, intraocu-
lar pressure, SFP, and retinal thickness measurements obtained
using both of the quantitative methods (the RTA and OCT). All
eyes had a best-corrected visual acuity of 20/20, clear media, no
neovascularization, and no CSME or previous laser treatment.
Fundus examination was performed by SLB using a +90-
diopter (D) lens and a Goldmann contact lens and 7-field SFP
obtained and classified by an independent grader (C.L.L.) ac-
cording to the criteria of the ETDRS protocol3 without being
aware of the RTA or OCT findings. Stereoscopic pairs of fields
were obtained using a 30° fundus camera. Ten eyes were clas-
sified as level 10 (DR absent) and 18 as level 20 or 35 (micro-
aneurysms only or mild nonproliferative DR, respectively). Only
1 eye of each patient was studied.
Retinal thickness was assessed after the clinical examina-
tion by using the RTA and OCT in a single session through a
dilated pupil (minimum of 5-6 mm), with drops of 2.5% phen-
ylephrine hydrochloride and 1% tropicamide, by an experi-
enced examiner (M.A.S.) who was aware of the clinical find-
ings. A single examination was performed using each method.
Before the study, a full explanation of the procedure was given
to all participants, and informed consent was obtained in all
cases. Tenets of the Declaration of Helsinki were followed.
Two healthy populations volunteered to participate as age-
matched control groups for the RTA (n=14; mean age, 48 years;
age range, 42-55 years) and OCT (n=10; mean age, 56 years;
age range, 43-68 years). All of the individuals in these 2 control
groups underwent a complete ophthalmologic examination and
had a best-corrected visual acuity of 20/20 OU (refraction was
within 2 D of emmetropia), clear media, normal visual fields, and
absence of optic disc or retinal abnormalities on fundus exami-
nation (performed by SLB using a Goldmann contact lens). Reti-
nal thickness was measured in both eyes using the RTA and OCT
by the same examiner through a dilated pupil. Only 1 eye from
each volunteer was randomly selected to compute RTA and OCT
reference maps, using the means+2 SDs. The following mean±SD
results were obtained: for the RTA — central foveal thickness,
141±18 µm; papillomacular area, 179±7 µm; superior area,
180±15 µm; temporal area, 176±17 µm; and inferior area,
169±17 µm; for OCT — central foveal thickness, 187±16 µm;
papillomacular area, 264±20 µm; superior area, 263±19 µm; tem-
poral area, 247±22 µm; and inferior area, 260±18 µm (Figure1).
RETINAL THICKNESS ANALYZER
The RTA is a quantitative and reproducible method for evalu-
ating retinal thickness.2,5,7-10
The principle of retinal thickness analysis is based on pro-
jecting a thin helium-neon laser (543-nm) slit obliquely on the
retina and viewing it at an angle in a manner similar to SLB.
The total area scanned with the RTA is 60006000 µm, with
each pixel representing an area of 200200 µm.
To compare RTA and OCT areas of thickness, a new thick-
ness map for the RTA measurements was built. Considering the
covered area for each single value of the RTA thickness map and
the areas covered at the 5 different locations of the OCT map, a
new thickness map of the RTA was computed. This map takes
into account the values that best fit the locations covered by the
OCT map (Figure 2). The software version used was the 2.11
with analysis 6.35 (Talia Technology Ltd).
OPTICAL COHERENCE TOMOGRAPHY
Optical coherence tomography is a diagnostic technique that pro-
vides cross-sectional tomographs of the retinal structure in vivo
in which optical interferometry is used to resolve the distances
of reflective structures within the eye. It is analogous to ultra-
sound B-scan but with superior resolution—approximately 10 µm
in the retina.6,11-13
Data are displayed in 2 different manners: as a numeric
report and as a false-color topographic map divided into 9
ETDRS-type regions. For each of these regions, an average reti-
nal thickness is automatically computed. In the color-coded map,
bright colors, such as red and white, correspond to optical re-








Figure 2. A, Best fit between retinal thickness analyzer (RTA) and optical
coherence tomography (OCT) measurements for the 5 locations of interest.
Each square represents an area measuring 200200 µm (RTA). Also shown
are 2 concentric circles with 1000- and 3000-µm radii, establishing the limits



























Figure 1. Retinal thickness analyzer (A) and optical coherence tomography
(B) reference maps from controls showing the mean±SD thickness values
for each of the 5 areas of interest. Values are given in micrometers for a right
eye. The 5 locations—the fovea (1000 µm) and the papillomacular, superior,
temporal, and inferior quadrants of the retina—were automatically measured
and averaged.
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Acquisition time is 1 second for each of the 6 radial lines
needed for a complete topographic macular examination. Pa-
tient discomfort, however, is minimal.
The software version used was A6.2 (Zeiss Humphrey
Systems).
LOCATIONS FOR RETINAL THICKNESS
MEASUREMENTS
The OCT scans were performed in the control and diabetic eyes
using the 6-radial-lines pattern, each 3.45 mm long, passing
through the center of fixation. The scanning protocol for reti-
nal mapping was first proposed by Hee et al.6 Each of the 6 to-
mograms (B-scans) was oriented along a line intersecting the
central fovea and containing 100 equally spaced axial profiles
(A-scans) of optical reflectivity.
For this study, 5 measurements of retinal thickness were
considered. These 5 values were automatically obtained in 5
retinal locations within a circle: a central disc area of 1 mm in
diameter, centered on the patient’s fixation, which was as-
sumed to correspond to the central fovea, and in a peripheral
ring area, 3 mm in diameter, in 4 retinal quadrants—papillo-
macular, superior, temporal, and inferior (Figure 2).
The RTA scans were obtained from the same diabetic eyes
by the same examiner (M.A.S.). Retinal thickness measure-
ments made by the RTA, as previously stated, produce an out-
put map in which each value covers an area of 200200 µm.
To compare the measurements made by the 2 instruments, a
best-fit overlapping area of both measures was found (Figure
2). Figure 2 shows 2 concentric circles of 1000- and 3000-µm
radii. The shaded squares represent locations of RTA measure-
ments to be considered for each of the 5 locations of the OCT
measurements (Figure 2A) and the locations of general RTA
measurements vs OCT line measurements (Figure 2B).
As a result, the central site of the OCT measures an area of
0.79 mm2, and the RTA squares cover an area of 0.84 mm2, which
is the closest area possible, representing an increase of 6% in total
area for this location. For the remaining locations (superior, in-
ferior, papillomacular, and temporal), the process repeats, with
the OCT covering an area of 1.57 mm2 and the RTA covering an
area of 1.40 mm2 (12% more area covered by the OCT).
Although in the central area (1 mm in diameter) the in-
formation provided by each method can be assumed to be equally
detailed in both methods, as we get away from the central fo-
vea, the information provided by the RTA is more detailed than
that given by OCT. Optical coherence tomography keeps its
measurements along a line, not evaluating the thickness in the
areas between the lines. As a result, 1.5 mm from the center of
the fovea, that is, at the outer frontier of the 3-mm ring, the
distances between OCT measurements (one line to the next)
are larger than 750 µm.
DATA ANALYSIS
Retinal thickness maps of the eyes from diabetic patients un-
der study were obtained using the RTA and OCT. Moreover,
maps of increased thickness were computed by comparing the
thickness values of the eyes under study with both reference
maps (means+2 SDs) established for the RTA and OCT using
a reference population. Reproducibility data for the RTA and
OCT can be found elsewhere.8,9,11,13-15
RESULTS
The results are summarized in the Table. The RTA de-
tected thickness increases in 24 of 28 patients, with val-
ues ranging from 0.3% to 73.5%. The RTA increased val-
ues were noted in at least 1 location in all level 10 patients,
in 8 of 11 level 20 patients, and in 6 of 7 level 35 pa-
tients. Furthermore, increased thickness was detected in
more than 1 location simultaneously in 18 patients, and
9 patients had increased thickness in all 5 locations ex-
amined. These 9 patients—3 graded as level 10 (pa-
tients 1, 3, and 7), 4 as level 20 (patients 11, 12, 15, and
19), and 2 as level 35 (patients 26 and 27)—seem to have
a more diffuse type of macular thickening that may oc-
cur independently of the retinopathy photographic level.
Four patients—3 graded as level 20 (patients 11, 15, and
19) and 1 as level 35 (patient 27)—had marked central
foveal thickness (increases 20% higher than the refer-
ence values). No eye graded level 10 showed increases
in retinal thickness higher than 20%. The Table shows
that these large increases are accompanied by similar large
increases in the 4 remaining areas.
Optical coherence tomography detected retinal thick-
ness increases in 2 level 10 eyes (patients 3 and 7) and
in 1 level 35 eye (patient 23) ranging from 0.3% to 4.8%,
always located on the foveal area.
The RTA and OCT retinal thickness increases were
the same in patients 3 and 7 in the central fovea. How-
ever, patient 19 showed a large increase in thickness as
measured by the RTA in the foveal area (73.5%), whereas
OCT detected no change. On the other hand, OCT de-
tected an increase in central foveal thickness of 0.8% in
patient 23, but the RTA did not show any increase.
Patients in this study showed acceptable glyco-
sylated hemoglobin levels, with a mean value of 7.3%,
indicating a general situation of relatively good meta-
bolic control, with duration of diabetes mellitus ranging
from 1 to 20 years (mean, 7.9 years). No direct correla-
tion could be established between increases in retinal
thickness and duration of disease or short-term status of
metabolic control.
COMMENT
Results of the present study show that localized areas of
retinal edema, that is, areas of abnormal increase in reti-
nal thickness, are occurring in the macula in the early
stages of diabetic retinal disease. Localized areas of in-
creased retinal thickness were identified by the RTA in
24 of the 28 eyes examined but by OCT in only 3 of the
28 eyes.
All 10 eyes with no visible retinopathy showed
localized areas of abnormal increase with the RTA.
Although the increases were minimal in 4 eyes, they
were greater than the values of a reference popula-
tion (means+2 SDs). Optical coherence tomography
detected increases in retinal thickness in only 2 of
these eyes.
Of 18 eyes with mild nonproliferative retinopathy
of level 20 or 35 using the Wisconsin grading, based on
SFP, 14 showed localized areas of increased retinal thick-
ness when using the RTA, whereas only 1 showed in-
creased retinal thickness in the fovea using OCT. In this
study, the RTA detects abnormal increases in retinal thick-
ness in the diabetic retina before OCT. The results ob-
tained using the RTA demonstrate that localized retinal
edema is one of the earliest alterations occurring in the
(REPRINTED) ARCH OPHTHALMOL / VOL 120, OCT 2002 WWW.ARCHOPHTHALMOL.COM
1303
©2002 American Medical Association. All rights reserved.
 at CENTRO HOSP DA UNIVERSIDADE COIMBRA, on November 29, 2010 www.archophthalmol.comDownloaded from 
macula in eyes with type 2 diabetes mellitus. In this study,
however, OCT did not show these areas of localized reti-
nal edema. Hee et al,6 using OCT for screening for macu-
lar edema, showed similar results. They detected in-
creased foveal thickness in only 2 of 55 eyes from 31
patients who had no visible retinopathy.
The localized areas of retinal edema detected in the
fovea by the RTA showed increases in retinal thickness
that varied from 0.3% to 73.5% higher than the refer-
ence values for the respective area under evaluation. The
highest increase in eyes with Wisconsin grading level
10 was 19.2%, whereas larger increases reaching 56.5%
and 73.5% were detected in eyes graded as level 20 or
35. Although our results indicate that increases in reti-
nal thickness are an early finding in diabetic retinas, they
also show that more marked increases in retinal thick-
ness are associated with progression of the retinal mi-
crovascular alterations. It is also shown in this study that
the development of localized areas of retinal edema is not
a constant finding, as 4 of 28 eyes remained edema free.
No clear correlation was found in this study among
duration of disease, level of metabolic control, and the
presence of localized areas of retinal edema.
Evidence from previous studies by Lobo et al,16,17
using integrated data obtained with the retinal leakage
analyzer and the RTA, indicates that 2 types of retinal
edema may occur simultaneously in the earliest stages
of diabetic retinal disease: retinal edema of the cytotoxic
type, occurring independently of an associated break-
down of the blood-retinal barrier, and a vasogenic type
of edema directly due to alteration of the blood-retinal
barrier.
In a subsequent 1-year follow-up study17 of eyes with
minimal nonproliferative retinopathy in patients with type
2 diabetes mellitus, retinal edema was shown to be pre-
dominantly of the vasogenic type, that is, due to an al-
teration of the blood-retinal barrier. In that same study,
the extent and height of the retinal edema did not cor-
relate with the levels of metabolic control.
The reference values and SDs obtained by the RTA
and OCT in the present study were similar to those
reported in the literature. The central macular thickness
in a similarly aged group examined by the RTA and
OCT showed mean ± SD values of 141 ± 18 µm and
187±16 µm, respectively. None of the eyes included in
this study had the characteristics of CSME, as described
in the ETDRS, and all the diabetic patients had 20/20
visual acuity.
The absolute values of macular thickness quanti-
fied by the RTA and OCT are still uncertain because
Retinal Thickness Increases Detected by OCT and the RTA in Patients With Diabetic Retinopathy*
Patient No./Age, y/

















OCT RTA OCT RTA OCT RTA OCT RTA OCT RTA
1/57/20 6.7 L 10 0.0 1.8 0.0 17.7 0.0 12.1 0.0 0.4 0.0 6.0
2/53/5 5.7 L 10 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0
3/67/16 7.7 R 10 0.3 4.0 0.0 21.4 0.0 15.0 0.0 1.2 0.0 4.3
4/58/4 11.7 R 10 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0
5/63/6 6.3 R 10 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0
6/61/3 7.6 L 10 0.0 0.0 0.0 29.4 0.0 20.6 0.0 8.1 0.0 7.4
7/67/8 7.2 R 10 4.8 11.8 0.0 26.1 0.0 25.3 0.0 17.0 0.0 14.9
8/50/12 6.3 L 10 0.0 19.2 0.0 37.0 0.0 12.4 0.0 0.0 0.0 0.0
9/57/10 7.5 R 10 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0
10/55/5 9.5 L 10 0.0 10.9 0.0 28.4 0.0 7.4 0.0 0.0 0.0 0.5
11/56/7 5.7 R 20 0.0 22.8 0.0 40.7 0.0 24.1 0.0 25.7 0.0 19.8
12/58/8 8.1 L 20 0.0 6.5 0.0 16.8 0.0 8.2 0.0 3.3 0.0 6.9
13/54/15 6.7 R 20 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
14/54/5 7.5 L 20 0.0 3.1 0.0 13.4 0.0 2.8 0.0 0.0 0.0 0.0
15/53/8 6.8 L 20 0.0 23.1 0.0 40.0 0.0 22.9 0.0 19.1 0.0 24.6
16/66/4 6.3 L 20 0.0 15.9 0.0 3.0 0.0 5.8 0.0 3.0 0.0 0.0
17/54/15 7.8 R 20 0.0 0.0 0.0 15.3 0.0 11.8 0.0 15.3 0.0 1.9
18/65/8 6.2 R 20 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
19/61/2 9.4 L 20 0.0 73.5 0.0 55.8 0.0 36.8 0.0 31.1 0.0 43.1
20/63/1 5.6 R 20 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0
21/69/4 6.1 R 20 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
22/63/4 6.2 R 35 0.0 0.0 0.0 2.3 0.0 8.6 0.0 0.0 0.0 0.0
23/66/6 7.3 R 35 0.8 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0
24/65/15 8.5 L 35 0.0 0.0 0.0 6.8 0.0 0.3 0.0 0.0 0.0 0.0
25/55/7 9.5 R 35 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
26/56/10 6.7 L 35 0.0 7.2 0.0 33.1 0.0 19.0 0.0 9.4 0.0 13.5
27/52/10 9.3 R 35 0.0 56.5 0.0 47.4 0.0 31.9 0.0 24.8 0.0 38.4
28/59/3 5.5 R 35 0.0 8.4 0.0 22.5 0.0 0.0 0.0 0.0 0.0 0.0
*OCT indicates optical coherence tomography; RTA, retinal thickness analyzer; DM, diabetes mellitus; L, left; and R, right.
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comparison between the in vivo retinal thickness mea-
surements and histologic analysis has not been con-
ducted owing to the associated problems. In vitro reti-
nal thickness measurements reported in the literature18,19
establish a range of 100 to 130 µm for the central foveal
thickness.
Several authors have published different measures
for foveal thickness using the RTA. Zeimer8 stated a ref-
erence retinal thickness of 167 µm in the fovea, with mean
local variation of 23 µm. Landau et al9 make reference
to 178 µm. These authors used a previous software ver-
sion in which the thickness was considered the distance
between the sites of maximal steepness of the slit pro-
file. Currently, the thickness is considered the distance
between the peaks of 2 lorentzian curves fitted to the slit
profile.2 Particular attention should be given to this fact
when comparing different reference values, as not all au-
thors make reference to the software versions used or the
area covered in the “foveal area.” Konno et al10 used only
the minimum value in field 5 of the thickness map and
found a mean±SD retinal thickness of 107±18.6 µm us-
ing software version 2.13 with analysis version 6.30. Neu-
bauer et al,14 using RTA software version 3 with analysis
version 7.06, found a mean±SD value of 181±17 µm.
They also found a median of 150 µm, which means that
there is equal probability of finding higher and lower val-
ues from this mark.
For OCT, Hee et al6 found a mean±SD retinal thick-
ness of 174±18 µm for the central 500 µm. Konno et al10
found a mean±SD value of 155±15 µm using software
version A4.01 and looking for “. . . the minimum value
located near the center of the image.” Massin et al15 found
a mean±SD value for a central area 1 mm in diameter
centered on the fovea of 178±17 µm using software ver-
sion A5, which differs 9 µm from our results. Finally, Neu-
bauer et al14 found a mean±SD value of 153±16 µm us-
ing software version A4.1. Again, they found a median
value of 150 µm, the same median as they found for the
RTA.
We established both reference populations in our
site. If there is any difference in age-matched popula-
tions for the RTA and OCT, it would mean a disadvan-
tage for the RTA because the RTA population is younger.
Zeimer8 states that there is a decrease of 5% per year in
macular thickness.
Shahidi and associates,4 using the RTA, reported that
clinical examination with SLB permits detection of reti-
nal thickness only when it is more than 60% greater than
reference retinal thickness measurements. This is in agree-
ment with our findings. In our study, involving patients
who did not have CSME when examined by SLB and SPF
disclosed values in this borderline range in the central
foveal area in only 2 of the 28 eyes.
There are obvious differences in the technique pro-
ducing the measurements and the thickness maps
between the RTA and OCT. Whereas in the central
foveal area the information provided by each method
can be assumed to be equally detailed, as we get
away from the central fovea, the information provided
by the RTA is clearly more detailed than that given by
OCT. Optical coherence tomography makes its
measurements along lines, not evaluating the thick-
ness in the areas between the lines. This is shown in
Figure 2.
In our clinical experience with these methods, an-
other advantage of the RTA is its short acquisition time.
The 200 milliseconds required for the scanning proce-
dure are associated with less discomfort to the patient
because of less prolonged light exposures. Also, with the
RTA, it is easier for patients to maintain steady ocular
fixation, and there are fewer problems associated with
blinking. On the other hand, in more advanced stages of
retinopathy, RTA results may be affected by irregular re-
flections from hard exudates accumulated in the retina
and by the interference of media opacities such as se-
vere cataract or vitreous opacities.
Comparing the 2 techniques to measure retinal
thickness, the RTA seems to be particularly appropriate
for measuring changes in retinal thickness when these
changes are minimal, particularly in the initial stages of
diabetic retinal disease and in eyes without media
opacities and in the absence of morphologic retinal
alterations, such as hard exudates. We consider the
RTA to be a promising tool to evaluate quantitatively
the changes in retinal thickness before the develop-
ment of CSME, when an early therapeutic intervention
may be more effective. In our experience, OCT is par-
ticularly informative when there are changes in the reti-
nal architecture through the formation of cysts or local-
ized fluid detachments. None of these situations were
found in the eyes included in this study. Studies in
progress performed by our group examining the pres-
ence of macular edema after cataract surgery indicate
that OCT detects only abnormal retinal thickness val-
ues where there is some degree of visible fluid accumu-
lation and cystlike formations are found in OCT cross
sections.
In conclusion, localized areas of increased retinal
thickness (ie, edema) occur in the retina in type 2 dia-
betes mellitus in the initial stages of retinopathy. These
areas of localized retinal edema may be identified and
quantified by the RTA, offering a unique opportunity to
study the effects of early intervention in the evolution
of diabetic retinal edema to prevent its progression to
CSME.
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ARCHIVES Web Quiz Winner
C ongratulations to the winner of our February quiz, Luigi Capasso, MD, Il Universita` degli Studi di Napoli, Naples,Italy. The correct answer to our February challenge was calcium deposition. For a complete discussion of this case,
see the Clinicopathologic Reports, Case Reports, and Small Case Series section in the March ARCHIVES (Pandey SK, Werner L,
Apple DJ, Gravel J-P. Calcium precipitation on the optical surface of a foldable intraocular lens: a clinicopathological correla-
tions. Arch Ophthalmol. 2002;120:391-393).
Be sure to visit the Archives of Ophthalmology World Wide Web site (http://www.archophthalmol.com) and try your
hand at our Clinical Challenge Interactive Quiz. We invite visitors to make a diagnosis based on selected information from
a case report or other feature scheduled to be published in the following month’s print edition of the ARCHIVES. The first
visitor to e-mail our Web editors with the correct answer will be recognized in the print journal and on our Web site and will
also receive a free copy of the book One Hundred Years of JAMA Landmark Articles.
Figure 2. Photomicrograph of the explanted
opacified Hydroview intraocular lens (Bausch &
Lomb, Rochester, NY) showing the confluent
deposits on the anterior optical surface. The
polymethyl-methacrylate haptics are free of any
deposits (original magnification 100).
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